Baker McKenzie Baker McKenzie
How Can We Help?
  • Home
  • Expertise
  • Healthcare & Life Sciences

Healthcare & Life Sciences

Healthcare
Insight

Life Sciences Collaborations: Key Considerations in the COVID-19 Era

With the healthcare and life sciences sector at the heart of the pandemic, new issues are arising in the already complex world of life sciences collaborations. This document is a high-level guide that outlines a list of issues to consider in executing these types of agreements in the COVID-19 era.
Read More

Healthcare and life sciences are some of the largest and fastest-growing industries in the world, in addition to being the most regulated, with rapidly changing rules and regulations that often conflict from one country to another. Healthcare and life sciences companies face a number of challenges, including trying to understand how these laws impact their market and M&A strategies while contending with rising R&D costs, loss of patent protection of blockbuster drugs, pricing pressures, and competition from generics. Rapid convergence of the healthcare, life sciences and technology sectors requires even more legal expertise given the additional data privacy and intellectual property concerns.

Insight | Thought Leadership
Supply Chains Reimagined
With companies stabilizing supply chain operations and managing demand-side shocks, there is an opportunity to seek renewal through new, longer-term digital strategies.
Insight | Legal Alert
Life Sciences Collaborations: Key Considerations in the COVID-19 Era
We present some key considerations that companies in the sector need to bear in mind to cope with the growing complexities of licensing and collaboration agreements.
Insight
COVID-19: EU Leaders Reach Agreement on EUR 750 Billion (US 858 Billion) Recovery Plan
European leaders have agreed to create a recovery fund to support EU economies affected by COVID-19.
Insight | Legal Alert
Germany: COVID-19 Corporate Legal Guideline
Due to the situation caused by the spread of COVID-19, we have published a "Coronavirus - Legal Guide for Germany".
Insight | Handbook
Law on COVID19 in Poland - Handbook
A brief description of the changes most important for current and future economic landscape in Poland.
Insight | Handbook
Global Public M&A Guide
Guide looks at issues that typically occur during public M&A deals across 42 jurisdictions, regardless of industry or deal specifics.
Insight | Legal Alert
EMEA: Digital Health Solutions Survey
Top legal issues to bear in mind as you embark on your digital health journey.
Insight
US: Reopening Safely - Guidelines for Relying on EPA and State Policies Providing Relief from Environmental Compliance During COVID-19
Steps to prepare for reopening of operations.
Insight | Handbook
COVID-19 Global Guide on Public Contracting
This guide provides an overview of the measures made available for public contracting authorities in light of the global pandemic.
Insight | Handbook
Lifting the lid on the Work of the London Coronavirus Response Team
This article turns the clock back and shows how we as a firm dealt with the Coronavirus crisis.
View All Insight
News | Deal Announcement
Baker McKenzie legal advisor to Acarix in its oversubscribed rights issue of approximately SEK 56 million
Arcarix AB (publ) has completed a new share issue with preferential rights for Acarix’ ...
News | Case Announcement
Baker McKenzie successfully defends Berlin-Chemie AG rights in Nimesil vs. Nimesin trademark dispute
Baker McKenzie's Kyiv office has successfully represented Berlin-Chemie AG before the Ukrainian ...
News | Deal Announcement
Baker McKenzie advises BioMedPartners on € 10.7 Million Series A Financing in Tubulis
Baker McKenzie advised BioMedPartners, a European independent life science investment fund on the lead of a Series A Equity Financing of € 10.7 million to advance the development of a new class ...
News | Awards
Baker McKenzie practices and lawyers rated top by Ukrainian Law Firms 2020. A Handbook for Foreign Clients
Baker McKenzie’s Kyiv practices and lawyers received outstanding rankings and recommendations ...
News | Deal Announcement
Baker McKenzie advises Casdin Capital on a USD 50 million extension of the Series B Financing in DNA Script
Baker McKenzie advised Casdin Capital, an investment firm based in New York and focused on the ...
News | Deal Announcement
Baker McKenzie advises Casdin Capital as lead investor on a $50 Million extension to the Series B Financing in DNA Script
Baker McKenzie advised Casdin Capital, an investment firm based in New York focused on the life ...
News | Deal Announcement
Baker McKenzie advised Highbridge Capital Management on its financing for Santhera Pharmaceuticals
The financing takes the form of senior secured exchangeable notes, exchangeable into shares in Santhera Pharmaceuticals Holding AG.
News | Deal Announcement
Baker McKenzie advises CureVac AG on its strategic research collaboration with GSK
Baker McKenzie advised CureVac AG on a strategic collaboration agreement with GlaxoSmithKline (GSK) for the research, development, manufacturing and commercialisation of up to five mRNA-based vaccines ...
News | Firm News
Beyond COVID-19: Ukraine Legal Guide, 2nd Edition - Available Online
Baker McKenzie has the pleasure of announcing the publication of the second edition of Beyond COVID-19: Ukraine Legal Guide.
News | Deal Announcement
Baker McKenzie Wins for Bio-Rad Laboratories in Front of the Regional Administrative Court (TAR Lombardia)
The regional administrative court (TAR Lombardia) ascertained the legitimacy of Bio-Rad ...
View All News
  • Ranked in the Top 10 Law Firms in the world for Life Sciences, Chambers Global
  • Ranked Band 1 for Life Sciences, Chambers Asia Pacific 2014-2018
  • Medical Law Firm of the Year, ALB Southeast Asia Awards 2017
  • Most Innovative Use of Technology for the Pharma MapApp, FT Most Innovative Lawyer Awards, 2015
  • No. 1 Healthcare M&A firm by deal volume for past three years, Thomson Reuters 2017
  • No. 1 Healthcare M&A firm by cross-border deal volume for past five years, Thomson Reuters 2017

 

How We Can Help

Explore Healthcare & Life Sciences

Reshaping the Healthcare Sector Through M&A (in partnership with Financial Times)

A high-level virtual discussion exploring the ways in which M&A will reshape the sector and fast-track innovation

COVID-19: A Global Review of Healthcare and Life Sciences Industry Issues

Provides high-level answers to questions on market access, clinical trials, IP risks and telemedicine

About Us

Learn about our Global Healthcare & Life Sciences Industry Group in 3 minutes

Healthcare MapApp

Access real-time information on the laws and regulations affecting the healthcare and life sciences industries in more than 50 countries

Global Healthcare and Life Sciences Webinar Series

Learn about a spectrum of legal issues and hot topics in the healthcare and life sciences industries

Clinical Trials Handbook

Outlines the legal framework governing clinical trials of medicinal products in 34 jurisdictions

Promoting Medical Products Globally

Understand legal developments and regulations related to ethical business interactions between medical companies and healthcare professionals in 35 countries

Business success is being redefined as focus shifts to a greater purpose beyond profit. As COVID-19 puts a renewed spotlight on corporate citizenship, we can help you transform operations, manage risk and drive growth.

Key Contacts

We use cookies to improve your experience on our website. To find out more about the cookies we use and how to change your settings if you do not want cookies to be placed on your device, please read our Privacy and Cookies Statement.
Accept